Stronger blood clot warnings added to Bayer's Yaz, Yasmin
This article was originally published in Scrip
Executive Summary
The labelling for Bayer Healthcare's drospirenone-containing oral contraceptives Yaz, Yasmin, Beyaz and Safyral and generic versions of the agent are being revised to warn that the pills may be associated with a higher risk for blood clots than other progestin-containing contraceptives.